Welkom bij Scalda & Bohn Stafleu van Loghum
Scalda heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen.Je kunt de producten hieronder links aanschaffen en rechts inloggen.
Gepubliceerd in:
01-02-2010
De rol van presynaptische dopaminerge beeldvorming bij de ziekte van Parkinson
Auteur: Silvia Eshuis
Gepubliceerd in: Neuropraxis | Uitgave 1/2010
Log in om toegang te krijgenshare
DELEN
Deel dit onderdeel of sectie (kopieer de link)
-
Optie A:
-
Optie B:Deel de link per e-mail
Samenvatting
De ziekte van Parkinson is een langzaam progressieve degeneratieve aandoening die gekenmerkt wordt door progressieve degeneratie van dopaminerge neuronen in de substantia nigra. De klassieke trias van klinische symptomen van de ziekte van Parkinson bestaat uit: bradykinesie, rigiditeit en rusttremor. In het begin van de ziekte kunnen deze symptomen nog subtiel zijn en kan het daarom lastig zijn om uitsluitend op basis daarvan de juiste diagnose te stellen.
Log in om toegang te krijgen
Literatuur
go back to reference Antonini, A., Vontobel, P., Psylla, M., Gunther, I., Maguire, P.R., Missimer, J. & Leenders, K.L. (1995). Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson’s disease. Archives of Neurology, 52, 1183–1190.PubMedCrossRef
Antonini, A., Vontobel, P., Psylla, M., Gunther, I., Maguire, P.R., Missimer, J. & Leenders, K.L. (1995). Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson’s disease. Archives of Neurology, 52, 1183–1190.PubMedCrossRef
go back to reference Asenbaum, S., Brucke, T., Pirker, W., Podreka, I., Angelberger, P., Wenger, S., Wober, C., Muller, C. & Deecke, L. (1997). Imaging of dopamine transporters with iodine-123-beta-CIT and spect in Parkinson’s disease. Journal of Nuclear Medicine, 38, 1–6.PubMed
Asenbaum, S., Brucke, T., Pirker, W., Podreka, I., Angelberger, P., Wenger, S., Wober, C., Muller, C. & Deecke, L. (1997). Imaging of dopamine transporters with iodine-123-beta-CIT and spect in Parkinson’s disease. Journal of Nuclear Medicine, 38, 1–6.PubMed
go back to reference Benamer, H.T., Patterson, J., Wyper, D.J., Hadley, D.M., Macphee, G.J. & Grosset, D.G. (2000a). Correlation of Parkinson’s disease severity and duration with 123I-fp-cit spect striatal uptake. Movement Disorders, 15, 692–698.CrossRef
Benamer, H.T., Patterson, J., Wyper, D.J., Hadley, D.M., Macphee, G.J. & Grosset, D.G. (2000a). Correlation of Parkinson’s disease severity and duration with 123I-fp-cit spect striatal uptake. Movement Disorders, 15, 692–698.CrossRef
go back to reference Benamer, T.S., Patterson, J., Grosset, D.G., Booij, J., Bruin, K. de, Royen, E. van, Speelman, J.D., Horstink, M.H., Sips, H.J., Dierckx, R.A., Versijpt, J., Decoo, D., Van Der, L.C., Hadley, D.M., Doder, M., Lees, A.J., Costa, D.C., Gacinovic, S., Oertel, W.H., Pogarell, O., Hoeffken, H., Joseph, K., Tatsch, K., Schwarz, J. & Ries, V. (2000b). Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-fp-cit spect imaging: the [123I]-fp-cit study group. Movement Disorders, 15, 503–510.CrossRef
Benamer, T.S., Patterson, J., Grosset, D.G., Booij, J., Bruin, K. de, Royen, E. van, Speelman, J.D., Horstink, M.H., Sips, H.J., Dierckx, R.A., Versijpt, J., Decoo, D., Van Der, L.C., Hadley, D.M., Doder, M., Lees, A.J., Costa, D.C., Gacinovic, S., Oertel, W.H., Pogarell, O., Hoeffken, H., Joseph, K., Tatsch, K., Schwarz, J. & Ries, V. (2000b). Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-fp-cit spect imaging: the [123I]-fp-cit study group. Movement Disorders, 15, 503–510.CrossRef
go back to reference Booij, J., Bergmans P., Winogrodzka, A., Speelman, J.D. & Wolters, E.C. (2001). Imaging of dopamine transporters with [123I]fp-cit spect does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson’s disease. Synapse, 39, 101–108.PubMedCrossRef
Booij, J., Bergmans P., Winogrodzka, A., Speelman, J.D. & Wolters, E.C. (2001). Imaging of dopamine transporters with [123I]fp-cit spect does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson’s disease. Synapse, 39, 101–108.PubMedCrossRef
go back to reference Booij, J., Tissingh, G., Boer, G.J., Speelman, J.D., Stoof, J.C., Janssen, A.G., Wolters, E.C. & Royen, E.A van. (1997). [123I]fp-cit spect shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 62, 133–140.CrossRef
Booij, J., Tissingh, G., Boer, G.J., Speelman, J.D., Stoof, J.C., Janssen, A.G., Wolters, E.C. & Royen, E.A van. (1997). [123I]fp-cit spect shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 62, 133–140.CrossRef
go back to reference Dhawan, V., Ma, Y.L., Pillai, V., Spetsieris, P., Chaly, T., Belakhlef, A., Margouleff, C. & Eidelberg, D. (2002). Comparative analysis of striatal FDOPA uptake in Parkinson’s disease: Ratio method versus graphical approach. Journal of Nuclear Medicine, 43, 1324–1330.PubMed
Dhawan, V., Ma, Y.L., Pillai, V., Spetsieris, P., Chaly, T., Belakhlef, A., Margouleff, C. & Eidelberg, D. (2002). Comparative analysis of striatal FDOPA uptake in Parkinson’s disease: Ratio method versus graphical approach. Journal of Nuclear Medicine, 43, 1324–1330.PubMed
go back to reference Eidelberg, D., Takikawa, S., Dhawan, V., Chaly, T., Robeson, W., Dahl, R., Margouleff, D., Moeller, J.R., Patlak, C.S. & Fahn, S. (1993). Striatal F-18 Dopa Uptake - Absence of An Aging Effect. Journal of Cerebral Blood Flow and Metabolism 13, 881–888.PubMedCrossRef
Eidelberg, D., Takikawa, S., Dhawan, V., Chaly, T., Robeson, W., Dahl, R., Margouleff, D., Moeller, J.R., Patlak, C.S. & Fahn, S. (1993). Striatal F-18 Dopa Uptake - Absence of An Aging Effect. Journal of Cerebral Blood Flow and Metabolism 13, 881–888.PubMedCrossRef
go back to reference Eshuis, S.A., Jager, P.L., Maguire, R.P., Jonkman, S., Dierckx, R.A. & Leenders, K.L. (2009). Direct comparison of fp-cit spect and f-dopa pet in patients with Parkinson’s disease and healthy controls. European. Journal of Nuclear Medicine and Molecular Imaging, 36, 454–462.PubMedCrossRef
Eshuis, S.A., Jager, P.L., Maguire, R.P., Jonkman, S., Dierckx, R.A. & Leenders, K.L. (2009). Direct comparison of fp-cit spect and f-dopa pet in patients with Parkinson’s disease and healthy controls. European. Journal of Nuclear Medicine and Molecular Imaging, 36, 454–462.PubMedCrossRef
go back to reference Eshuis, S.A., Maguire, R.P., Leenders, K.L., Jonkman, S. & Jager, P.L. (2006). Comparison of fp-cit spect with f-dopa pet in patients with de novo and advanced Parkinson’s disease. Euopean. Journal of Nuclear Medicine and Molecular Imaging, 33, 200–209.CrossRef
Eshuis, S.A., Maguire, R.P., Leenders, K.L., Jonkman, S. & Jager, P.L. (2006). Comparison of fp-cit spect with f-dopa pet in patients with de novo and advanced Parkinson’s disease. Euopean. Journal of Nuclear Medicine and Molecular Imaging, 33, 200–209.CrossRef
go back to reference Fearnley, J.M. & Lees, A.J. (1991). Ageing and Parkinson’s disease: substantia nigra regional selectivity. Brain, 114 (Pt 5), 2283–2301.PubMedCrossRef
Fearnley, J.M. & Lees, A.J. (1991). Ageing and Parkinson’s disease: substantia nigra regional selectivity. Brain, 114 (Pt 5), 2283–2301.PubMedCrossRef
go back to reference Garnett, E.S., Nahmias, C. & Firnau, G. (1984). Central dopaminergic pathways in hemiparkinsonism examined by positron emission tomography. Canadian Journal of Neurological Science, 11, 174–179.
Garnett, E.S., Nahmias, C. & Firnau, G. (1984). Central dopaminergic pathways in hemiparkinsonism examined by positron emission tomography. Canadian Journal of Neurological Science, 11, 174–179.
go back to reference Goodman, M.M., Keil, R., Shoup, T.M., Eshima, D., Eshima, L., Kilts, C., Votaw, J., Camp, V.M., Votaw, D., Smith, E., Kung, M.P., Malveaux, E., Watts, R., Huerkamp, M., Wu, D., Garcia, E. & Hoffman, J.M. (1997). Fluorine-18-FPct: a pet radiotracer for imaging dopamine transporters. Journal of Nuclear Medicine, 38, 119–126.PubMed
Goodman, M.M., Keil, R., Shoup, T.M., Eshima, D., Eshima, L., Kilts, C., Votaw, J., Camp, V.M., Votaw, D., Smith, E., Kung, M.P., Malveaux, E., Watts, R., Huerkamp, M., Wu, D., Garcia, E. & Hoffman, J.M. (1997). Fluorine-18-FPct: a pet radiotracer for imaging dopamine transporters. Journal of Nuclear Medicine, 38, 119–126.PubMed
go back to reference Haaxma, C.A., Borm, G.F., Bloem, B.R. & Horstink, M.W.I.M. (2006). Gender differences in Parkinson’s disease. Movement Disorders, 21, S84.
Haaxma, C.A., Borm, G.F., Bloem, B.R. & Horstink, M.W.I.M. (2006). Gender differences in Parkinson’s disease. Movement Disorders, 21, S84.
go back to reference Haycock, J.W., Becker, L., Ang, L., Furukawa, Y., Hornykiewicz, O. & Kish, S.J. (2003). Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum. Journal of Neurochemistry, 87, 574–585.PubMedCrossRef
Haycock, J.W., Becker, L., Ang, L., Furukawa, Y., Hornykiewicz, O. & Kish, S.J. (2003). Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum. Journal of Neurochemistry, 87, 574–585.PubMedCrossRef
go back to reference Hilker, R., Thomas, A.V., Klein, J.C., Weisenbach, S., Kalbe E., Burghaus, L., Jacobs, A.H., Herholz, K. & Heiss, W.D. (2005). Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways. Neurology, 65, 1716–1722.PubMedCrossRef
Hilker, R., Thomas, A.V., Klein, J.C., Weisenbach, S., Kalbe E., Burghaus, L., Jacobs, A.H., Herholz, K. & Heiss, W.D. (2005). Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways. Neurology, 65, 1716–1722.PubMedCrossRef
go back to reference Hughes, A.J., Daniel, S.E., Ben Shlomo, Y. & Lees, A.J. (2002). The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain, 125, 861–870.PubMedCrossRef
Hughes, A.J., Daniel, S.E., Ben Shlomo, Y. & Lees, A.J. (2002). The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain, 125, 861–870.PubMedCrossRef
go back to reference Hughes, A.J., Daniel, S.E., Blankson, S. & Lees, A.J. (1993). A Clinicopathological Study of 100 Cases of Parkinson’s-Disease. Archives of Neurology, 50, 140–148.PubMedCrossRef
Hughes, A.J., Daniel, S.E., Blankson, S. & Lees, A.J. (1993). A Clinicopathological Study of 100 Cases of Parkinson’s-Disease. Archives of Neurology, 50, 140–148.PubMedCrossRef
go back to reference Ishikawa, T., Dhawan, V., Kazumata, K., Chaly, T., Mandel, F., Neumeyer, J., Margouleff, C., Babchyck, B., Zanzi, I. & Eidelberg, D. (1996). Comparative nigrostriatal dopaminergic imaging with iodine-123-beta cit/fpspect and fluorine-18-fdopa/pet. Journal of Nuclear Medicine, 37, 1760–1765.PubMed
Ishikawa, T., Dhawan, V., Kazumata, K., Chaly, T., Mandel, F., Neumeyer, J., Margouleff, C., Babchyck, B., Zanzi, I. & Eidelberg, D. (1996). Comparative nigrostriatal dopaminergic imaging with iodine-123-beta cit/fpspect and fluorine-18-fdopa/pet. Journal of Nuclear Medicine, 37, 1760–1765.PubMed
go back to reference Ito, Y., Fujita, M., Shimada, S., Watanabe, Y., Okada, T., Kusuoka, H., Tohyama, M. & Nishimura, T. (1999). Comparison between the decrease of dopamine transporter and that of l-dopa uptake for detection of early to advanced stage of Parkinson’s disease in animal models. Synapse, 31, 178–185.PubMedCrossRef
Ito, Y., Fujita, M., Shimada, S., Watanabe, Y., Okada, T., Kusuoka, H., Tohyama, M. & Nishimura, T. (1999). Comparison between the decrease of dopamine transporter and that of l-dopa uptake for detection of early to advanced stage of Parkinson’s disease in animal models. Synapse, 31, 178–185.PubMedCrossRef
go back to reference Kaasinen, V., Nurmi, E., Bruck, A., Bergman, J., Solin, O. & Rinne, J.O. (2001). Increased frontal [F-18]fluorodopa uptake in early Parkinson’s Disease: sex differences in the prefrontal cortex. Brain, 124, 1125–1130.PubMedCrossRef
Kaasinen, V., Nurmi, E., Bruck, A., Bergman, J., Solin, O. & Rinne, J.O. (2001). Increased frontal [F-18]fluorodopa uptake in early Parkinson’s Disease: sex differences in the prefrontal cortex. Brain, 124, 1125–1130.PubMedCrossRef
go back to reference Kazumata, K., Dhawan, V., Chaly, T., Antonini, A., Margouleff, C., Belakhlef, A., Neumeyer, J. & Eidelberg, D. (1998). Dopamine transporter imaging with fluorine-18-FPCIT and pet. Journal of Nuclear Medicine, 39, 1521–1530.PubMed
Kazumata, K., Dhawan, V., Chaly, T., Antonini, A., Margouleff, C., Belakhlef, A., Neumeyer, J. & Eidelberg, D. (1998). Dopamine transporter imaging with fluorine-18-FPCIT and pet. Journal of Nuclear Medicine, 39, 1521–1530.PubMed
go back to reference Kish, S.J., Zhong, X.H., Hornykiewicz, O. & Haycock, J.W. (1995). Striatal 3,4-dihydroxyphenylalanine decarboxylase in aging: disparity between postmortem and positron emission tomography studies? Annals of Neurology, 38, 260–264.PubMedCrossRef
Kish, S.J., Zhong, X.H., Hornykiewicz, O. & Haycock, J.W. (1995). Striatal 3,4-dihydroxyphenylalanine decarboxylase in aging: disparity between postmortem and positron emission tomography studies? Annals of Neurology, 38, 260–264.PubMedCrossRef
go back to reference Koerts, J., Leenders, K.L., Koning, M., Portman, A.T. & Beilen, M. van (2007). Striatal dopaminergic activity (fdopa-pet) associated with cognitive items of a depression scale (madrs) in Parkinson’s disease. European Journal of Neuroscience, 25, 3132–3136.PubMedCrossRef
Koerts, J., Leenders, K.L., Koning, M., Portman, A.T. & Beilen, M. van (2007). Striatal dopaminergic activity (fdopa-pet) associated with cognitive items of a depression scale (madrs) in Parkinson’s disease. European Journal of Neuroscience, 25, 3132–3136.PubMedCrossRef
go back to reference Kuhl, D.E., Minoshima, S., Fessler, J.A., Frey, K.A., Foster, N.L., Ficaro, E.P., Wieland, D.M. & Koeppe, R.A. (1996). In vivo mapping of cholinergic terminals in normal aging, Alzheimers disease, and Parkinson’s disease. Annals of Neurology, 40, 399–410.PubMedCrossRef
Kuhl, D.E., Minoshima, S., Fessler, J.A., Frey, K.A., Foster, N.L., Ficaro, E.P., Wieland, D.M. & Koeppe, R.A. (1996). In vivo mapping of cholinergic terminals in normal aging, Alzheimers disease, and Parkinson’s disease. Annals of Neurology, 40, 399–410.PubMedCrossRef
go back to reference Laakso, A., Vilkman, H., Bergman, J., Haaparanta, M., Solin, O., Syvalahti, E., Salokangas, R.K.R. & Hietala, J. (2002). Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects. Biological Psychiatry, 52, 759–763.PubMedCrossRef
Laakso, A., Vilkman, H., Bergman, J., Haaparanta, M., Solin, O., Syvalahti, E., Salokangas, R.K.R. & Hietala, J. (2002). Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects. Biological Psychiatry, 52, 759–763.PubMedCrossRef
go back to reference Lavalaye, J., Booij, J., Reneman, L., Habraken, J.B. & van Royen, E.A. (2000). Effect of age and gender on dopamine transporter imaging with [123I]FP- CIT Spet in healthy volunteers. Europan Journal of Nuclear Medicine, 27, 867–869.CrossRef
Lavalaye, J., Booij, J., Reneman, L., Habraken, J.B. & van Royen, E.A. (2000). Effect of age and gender on dopamine transporter imaging with [123I]FP- CIT Spet in healthy volunteers. Europan Journal of Nuclear Medicine, 27, 867–869.CrossRef
go back to reference Lee, C.S., Samii, A., Sossi, V., Ruth, T.J., Schulzer, M., Holden, J.E., Wudel, J., Pal, P.K., Fuente-Fernandez, R., Calne, D.B. & Stoessl, A.J. (2000). In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson’s disease. Annals of Neurology, 47, 493–503.PubMedCrossRef
Lee, C.S., Samii, A., Sossi, V., Ruth, T.J., Schulzer, M., Holden, J.E., Wudel, J., Pal, P.K., Fuente-Fernandez, R., Calne, D.B. & Stoessl, A.J. (2000). In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson’s disease. Annals of Neurology, 47, 493–503.PubMedCrossRef
go back to reference Leenders, K.L., Palmer, A.J., Quinn, N., Clark, J.C., Firnau, G., Garnett, E.S., Nahmias, C., Jones, T. & Marsden, C.D. (1986). Brain dopamine metabolism in patients with Parkinson’s disease measured with positron emission tomography. Journal of Neurology, Neurosurgery and Psychiatry, 49, 853–860.CrossRef
Leenders, K.L., Palmer, A.J., Quinn, N., Clark, J.C., Firnau, G., Garnett, E.S., Nahmias, C., Jones, T. & Marsden, C.D. (1986). Brain dopamine metabolism in patients with Parkinson’s disease measured with positron emission tomography. Journal of Neurology, Neurosurgery and Psychiatry, 49, 853–860.CrossRef
go back to reference Marek, K.L., Seibyl, J.P., Zoghbi, S.S., Zea-Ponce, Y., Baldwin, R.M., Fussell, B., Charney, D.S., Dyck, C. van, Hoffer, P.B. & Innis, R.P. (1996). [123I] beta-cit/spect imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson’s disease. Neurology, 46, 231–237.PubMedCrossRef
Marek, K.L., Seibyl, J.P., Zoghbi, S.S., Zea-Ponce, Y., Baldwin, R.M., Fussell, B., Charney, D.S., Dyck, C. van, Hoffer, P.B. & Innis, R.P. (1996). [123I] beta-cit/spect imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson’s disease. Neurology, 46, 231–237.PubMedCrossRef
go back to reference Martin, W.R.W., Palmer, M.R., Patlak, C.S. & Calne, D.B. (1989). Nigrostriatal Function in Humans Studied with Positron Emission Tomography. Annals of Neurology, 26, 535–542.PubMedCrossRef
Martin, W.R.W., Palmer, M.R., Patlak, C.S. & Calne, D.B. (1989). Nigrostriatal Function in Humans Studied with Positron Emission Tomography. Annals of Neurology, 26, 535–542.PubMedCrossRef
go back to reference Morrish, P.K., Sawle, G.V. & Brooks, D.J. (1995). Clinical and [18F] dopa pet findings in early Parkinson’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 59, 597–600.CrossRef
Morrish, P.K., Sawle, G.V. & Brooks, D.J. (1995). Clinical and [18F] dopa pet findings in early Parkinson’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 59, 597–600.CrossRef
go back to reference Niznik, H.B., Fogel, E.F., Fassos, F.F. & Seeman, P. (1991). The dopamine transporter is absent in parkinsonian putamen and reduced in the caudate nucleus. Journal of Neurochemistry, 56, 192–198.PubMedCrossRef
Niznik, H.B., Fogel, E.F., Fassos, F.F. & Seeman, P. (1991). The dopamine transporter is absent in parkinsonian putamen and reduced in the caudate nucleus. Journal of Neurochemistry, 56, 192–198.PubMedCrossRef
go back to reference Ota, M., Yasuno, F., Ito, H., Seki, C., Nozaki, S., Asada, T. & Suhara, T. (2006). Age-related decline of dopamine synthesis in the living human brain measured by positron emission tomography with L-[beta-11C]dopa. Life Science, 79, 730–736.CrossRef
Ota, M., Yasuno, F., Ito, H., Seki, C., Nozaki, S., Asada, T. & Suhara, T. (2006). Age-related decline of dopamine synthesis in the living human brain measured by positron emission tomography with L-[beta-11C]dopa. Life Science, 79, 730–736.CrossRef
go back to reference Paulus, W. & Jellinger, K. (1991). The neuropathologic basis of different clinical subgroups of Parkinson’s disease. Journal of Neuropathology and Experimental Neurology, 50, 743–755.PubMedCrossRef
Paulus, W. & Jellinger, K. (1991). The neuropathologic basis of different clinical subgroups of Parkinson’s disease. Journal of Neuropathology and Experimental Neurology, 50, 743–755.PubMedCrossRef
go back to reference Pirker, W. (2003). Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it? Movement Disorders, 18, Supplement 7, S43–S51.PubMedCrossRef
Pirker, W. (2003). Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it? Movement Disorders, 18, Supplement 7, S43–S51.PubMedCrossRef
go back to reference Ryding, E., Lindstrom, M., Bradvik, B., Grabowski, M., Bosson, P., Traskman-Bendz, L. & Rosen, I. (2004). A new model for separation between brain dopamine and serotonin transporters in I-123-beta-cit spect measurements: normal values and sex and age dependence. European Journal of Nuclear Medicine and Molecular Imaging, 31, 1114–1118.PubMedCrossRef
Ryding, E., Lindstrom, M., Bradvik, B., Grabowski, M., Bosson, P., Traskman-Bendz, L. & Rosen, I. (2004). A new model for separation between brain dopamine and serotonin transporters in I-123-beta-cit spect measurements: normal values and sex and age dependence. European Journal of Nuclear Medicine and Molecular Imaging, 31, 1114–1118.PubMedCrossRef
go back to reference Sawle, G.V., Colebatch, J.G., Shah, A., Brooks, D.J., Marsden, C.D. & Frackowiak, R.S.J. (1990). Striatal Function in Normal Aging - Implications for Parkinson’s-Disease. Annals of Neurology, 28, 799–804.PubMedCrossRef
Sawle, G.V., Colebatch, J.G., Shah, A., Brooks, D.J., Marsden, C.D. & Frackowiak, R.S.J. (1990). Striatal Function in Normal Aging - Implications for Parkinson’s-Disease. Annals of Neurology, 28, 799–804.PubMedCrossRef
go back to reference Seibyl, J.P., Marek, K., Sheff, K., Zoghbi, S., Baldwin, R.M., Charney, D.S. Dyck, C.H. van & Innis, R.B. (1998). Iodine-123-beta-cit and iodine-123-fpcit spect measurement of dopamine transporters in healthy subjects and Parkinson’s patients. Journal of Nuclear Medicine, 39, 1500–1508.PubMed
Seibyl, J.P., Marek, K., Sheff, K., Zoghbi, S., Baldwin, R.M., Charney, D.S. Dyck, C.H. van & Innis, R.B. (1998). Iodine-123-beta-cit and iodine-123-fpcit spect measurement of dopamine transporters in healthy subjects and Parkinson’s patients. Journal of Nuclear Medicine, 39, 1500–1508.PubMed
go back to reference Seibyl, J.P., Marek, K.L., Quinlan, D., Sheff, K., Zoghbi, S., Zea-Ponce, Y., Baldwin, R.M., Fussell, B., Smith, E.O., Charney, D.S., et al. (1995). Decreased single-photon emission computed tomographic [123I]beta-cit striatal uptake correlates with symptom severity in Parkinson’s disease. Annals of Neurology, 38, 589–598.PubMedCrossRef
Seibyl, J.P., Marek, K.L., Quinlan, D., Sheff, K., Zoghbi, S., Zea-Ponce, Y., Baldwin, R.M., Fussell, B., Smith, E.O., Charney, D.S., et al. (1995). Decreased single-photon emission computed tomographic [123I]beta-cit striatal uptake correlates with symptom severity in Parkinson’s disease. Annals of Neurology, 38, 589–598.PubMedCrossRef
go back to reference Staley, J.K., Krishnan-Sarin, S., Zoghbi, S., Tamagnan, G., Fujita, M., Seibyl, J.P., Maciejewski, P.K., O’Malley, S. & Innis, R.B. (2001). Sex differences in [I-123]beta-cit spect measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers. Synapse, 41, 275–284.PubMedCrossRef
Staley, J.K., Krishnan-Sarin, S., Zoghbi, S., Tamagnan, G., Fujita, M., Seibyl, J.P., Maciejewski, P.K., O’Malley, S. & Innis, R.B. (2001). Sex differences in [I-123]beta-cit spect measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers. Synapse, 41, 275–284.PubMedCrossRef
go back to reference Tissingh, G., Bergmans, P., Booij, J., Winogrodzka, A., Royen, E.A. van, Stoof, J.C. & Wolters, E.C. (1998). Drug-naive patients with Parkinson’s disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]beta-cit spect. Journal of Neurology, 245, 14–20.PubMedCrossRef
Tissingh, G., Bergmans, P., Booij, J., Winogrodzka, A., Royen, E.A. van, Stoof, J.C. & Wolters, E.C. (1998). Drug-naive patients with Parkinson’s disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]beta-cit spect. Journal of Neurology, 245, 14–20.PubMedCrossRef
go back to reference Vingerhoets, F.J.G., Snow, B.J., Schulzer, M., Morrison, S., Ruth, T.J., Holden, J.E., Cooper, S. & Calne, D.B. (1994). Reproducibility of Fluorine-18-6-Fluorodopa Positron Emission Tomography in Normal Human-Subjects. Journal of Nuclear Medicine, 35, 18–24.PubMed
Vingerhoets, F.J.G., Snow, B.J., Schulzer, M., Morrison, S., Ruth, T.J., Holden, J.E., Cooper, S. & Calne, D.B. (1994). Reproducibility of Fluorine-18-6-Fluorodopa Positron Emission Tomography in Normal Human-Subjects. Journal of Nuclear Medicine, 35, 18–24.PubMed
go back to reference Volkow, N.D., Ding, Y.S., Fowler, J.S., Wang, G.J., Logan, J., Gatley, S.J., Hitzemann, R., Smith, G., Fields, S.D. & Gur, R. (1996). Dopamine transporters decrease with age. C 37, 554–559.
Volkow, N.D., Ding, Y.S., Fowler, J.S., Wang, G.J., Logan, J., Gatley, S.J., Hitzemann, R., Smith, G., Fields, S.D. & Gur, R. (1996). Dopamine transporters decrease with age. C 37, 554–559.
go back to reference Weintraub, D., Newberg, A.B., Cary, M.S., Siderowf, A.D., Moberg, P.J., Kleiner-Fisman, G., Duda, J.E., Stern, M.B., Mozley, D. & Katz, I.R. (2005). Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson’s disease. Journal of Nuclear Medicine, 46, 227–232.PubMed
Weintraub, D., Newberg, A.B., Cary, M.S., Siderowf, A.D., Moberg, P.J., Kleiner-Fisman, G., Duda, J.E., Stern, M.B., Mozley, D. & Katz, I.R. (2005). Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson’s disease. Journal of Nuclear Medicine, 46, 227–232.PubMed
go back to reference Winogrodzka, A., Bergmans, P., Booij, J., Royen, E.A. van, Stoof, J.C. & Wolters, E.C. (2003). [(123)I]beta-cit spect is a useful method for monitoring dopaminergic degeneration in early stage Parkinson’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 74, 294–298.CrossRef
Winogrodzka, A., Bergmans, P., Booij, J., Royen, E.A. van, Stoof, J.C. & Wolters, E.C. (2003). [(123)I]beta-cit spect is a useful method for monitoring dopaminergic degeneration in early stage Parkinson’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 74, 294–298.CrossRef
go back to reference Zigmond, M.J., Berger, T.W., Grace, A.A. & Stricker, E.M. (1989). Compensatory responses to nigrostriatal bundle injury. Studies with 6-hydroxydopamine in an animal model of parkinsonism. Molecular and Chemical Neuropathology, 10, 185–200.PubMedCrossRef
Zigmond, M.J., Berger, T.W., Grace, A.A. & Stricker, E.M. (1989). Compensatory responses to nigrostriatal bundle injury. Studies with 6-hydroxydopamine in an animal model of parkinsonism. Molecular and Chemical Neuropathology, 10, 185–200.PubMedCrossRef
Metagegevens
- Titel
- De rol van presynaptische dopaminerge beeldvorming bij de ziekte van Parkinson
- Auteur
-
Silvia Eshuis
- Publicatiedatum
- 01-02-2010
- Uitgeverij
- Bohn Stafleu van Loghum
- Gepubliceerd in
-
Neuropraxis
/ Uitgave 1/2010
Print ISSN: 1387-5817
Elektronisch ISSN: 1876-5785 - DOI
- https://doi.org/10.1007/s12474-010-0003-4
